A QC Microbiologist plays a critical role in ensuring the microbial safety and quality of products by conducting rigorous testing throughout the manufacturing process. Their responsibilities include detecting and identifying microbial contaminants such as bacteria, fungi, and yeast in raw materials, in-process samples, and finished goods. They employ techniques like culture methods, microscopy, polymerase chain reaction (PCR), and bioburden testing to monitor microbial limits and sterility. By ensuring that microbial contamination is controlled, QC Microbiologists help prevent product spoilage and potential health risks to patients. They also work closely with production and quality assurance teams to investigate and resolve any contamination issues swiftly.
Beyond routine testing, a QC Microbiologist is involved in validating cleaning procedures, environmental monitoring, and maintaining aseptic processing conditions. They ensure that laboratory practices and testing protocols comply with regulatory standards and Good Manufacturing Practices (GMP). Documentation accuracy and timely reporting are essential aspects of their work to support regulatory audits and maintain compliance. With the increasing complexity of manufacturing environments and stricter safety requirements, QC Microbiologists must stay updated on new testing methodologies and technological advances. Their expertise is fundamental in safeguarding product sterility and overall quality, ultimately protecting patient health and supporting product reliability.
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Analytical strategies for solid-state forms in drug development
Maria Cristina Gamberini, University of Modena e Reggio Emilia, Italy
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Search for novel biomarkers and therapeutic targets for inflammatory disease
Madhav Bhatia, University of Otago, New Zealand
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico
Title : Abuse-deterrent dosage form technique utilizing a fusion of innovative pharmaceuticals and ion exchange resin
Bhupendra Gopalbhai Prajapati, Parul University, India
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia